Why Did Centene Stock Fall So Hard?
Centene fell so hard because the business it was growing fastest, ACA Marketplace insurance, turned out to be far costlier than it had priced for. In July 2025 it withdrew its guidance, the shares collapsed, and the year ended in a multi-billion-dollar loss.
- A year later the picture has reversed: second-quarter 2026 adjusted EPS was $2.51 against a loss of $0.16 a year earlier, its health benefits ratio fell to 89.6% from 93.0%, and guidance was raised to more than $4.80.
- The shares closed at $70.17 on October 23, up 95% in a year and about double their March level.
- The risks are policy, Medicaid rates and a shrinking Marketplace.
This is analysis, not a recommendation.
What went wrong in 2025?
Centene is one of the largest US insurers for government programmes: Medicaid, ACA Marketplace plans and Medicare. Its Marketplace business had grown quickly as enrolment rose. In July 2025 it withdrew its full-year guidance after data on risk adjustment, the payments between insurers that depend on how sick each insurer's members are, showed its Marketplace members were more costly than expected. Medical costs ran above premiums, the second quarter of 2025 produced a GAAP loss of $253 million and an adjusted loss of $0.16 a share, and later in 2025 the company recorded a goodwill write-down that produced a net loss of about $6.6 billion for the year, according to press reports.
The core problem was simple: for an insurer, premiums are set before costs are known, and when costs rise faster than premiums the loss is immediate. The shares reflected that, and the lows of 2025 were far below today's price.
What has changed since?
| Measure | Q2 2025 | Q2 2026 |
|---|---|---|
| Adjusted EPS | -$0.16 | $2.51 |
| GAAP EPS | -$0.51 | $2.19 |
| Total revenue | $48.7 billion | $53.6 billion (+9.9%) |
| Health benefits ratio (consolidated) | 93.0% | 89.6% |
| Commercial (Marketplace) benefits ratio | 90.6% | 79.2% |
| Medicaid benefits ratio | 94.9% | 93.9% |
| Marketplace members | 5.86 million | 3.49 million (-40%) |
| Medicaid members | 12.82 million | 12.11 million (-5.5%) |
Centene's Q2 2026 health benefits ratio by line, from its July 28, 2026 release. A lower ratio means more of each premium dollar is left after medical costs.
The fix was repricing Marketplace plans, letting members who were costly leave (membership fell 40%) and tightening Medicaid cost management. The commercial ratio fell from 90.6% to 79.2%. Management raised 2026 adjusted EPS guidance to more than $4.80, partly from about $0.50 of non-recurring items in Medicare and Commercial, and raised revenue guidance by $6 billion.
What risks remain?
| Risk | What is known |
|---|---|
| Medicaid | The ratio is still the highest at 93.9%, membership fell 5.5% and was expected to fall more by year-end; states are tightening eligibility ahead of work requirements phasing in during 2027 and 2028 |
| ACA Marketplace policy | The release names the renewal of enhanced premium tax credits and CMS programme-integrity initiatives as uncertain, and Marketplace volume has already fallen sharply |
| Rates | Government payers can cut or delay payments, and Medicaid rate adequacy is the key question for margins |
| Balance sheet | Total debt of $16.1 billion and goodwill of $10.8 billion |
| Medicare | Star ratings and cut points can change quickly, and Centene is simplifying its Medicare Advantage business |
What does the stock look like now?
After the collapse, the shares have come back: $70.17 on October 23, just 1.5% below a 52-week high of $71.71, against about $34 in March. Zacks, TIKR and others describe a rebound driven by earnings beats and guidance raises, with a first-quarter adjusted EPS of $3.37 against $2.13 expected. That means much of the recovery is already in the price.
| Measure | CNC | What it tells you |
|---|---|---|
| Price | $70.17 | 2% below its 52-week high of $71.71 |
| Market value | $35.1 billion | Total value of all shares |
| Trailing / forward P/E | n/a / 14.4 | No trailing P/E because trailing earnings are negative, forward is on 2026 estimates |
| Price to sales / price to book | 0.2 / 1.6 | This site's limits are 7 and 8 |
| Revenue growth / net margin | +17.0% / -3.3% | Trailing twelve months, with the 2025 loss still in the net margin |
| Debt to equity | 0.71 | Total debt against shareholders' equity |
| 1-year change / RSI | +94.8% / 61.0 | RSI below 30 is oversold, above 70 is overbought |
| Value filters passed | 3 of 8 | This site's eight mechanical value filters |
| Margin of safety (DCF) | +76.5% | A free-cash-flow DCF is distorted by claims-payment timing at an insurer |
This site's DCF margin of safety should be treated carefully for an insurer because free cash flow moves with when claims are paid. See how to check if a stock is a value trap for the tests, and what is a good P/E ratio for why a forward multiple of 14.4 depends on estimates holding.
What should you read next?
Two more explainers on companies in the same screen: is CenterPoint a safe utility for dividends, and why does natural gas drive CF Industries.
Sources
- Centene Q2 2026 earnings release (SEC, July 28, 2026): results, ratios, membership, guidance
- MarketBeat via Yahoo Finance: Centene reaffirms 2026 EPS outlook (September 20, 2026): Medicaid outlook and policy risks
- TIKR: Centene stock surges after Q1 2026 earnings beat: rebound and March price
- Centene on this site: price and ratios, October 23, 2026
The 2025 events (guidance withdrawal, write-down, net loss) are summarised from press coverage and the year-ago comparisons in the release, not from the 2025 filings, and two articles could not be read. Sources conflict on the 2026 benefits-ratio target, so the release's range of 90.5% to 91.3% is used. This is educational content, not investment advice.
For the largest insurer-and-PBM combination, which has avoided a collapse like this one, see Cigna.
Centene stock FAQ
Why did Centene stock crash in 2025?
Its ACA Marketplace members cost more than it had priced for, shown in risk-adjustment data, so it withdrew guidance in July 2025 and later reported a multi-billion-dollar loss.
Has Centene recovered?
Operationally yes: adjusted EPS was $2.51 in Q2 2026 and the benefits ratio fell to 89.6%. The shares are about double their March level and near a 52-week high.
What is Centene's 2026 guidance?
Adjusted EPS of more than $4.80 and revenue of $193.5 billion to $197.5 billion, raised on July 28, 2026.
What are the biggest risks now?
Medicaid rates and enrolment, ACA subsidy and programme-integrity policy, Medicare star ratings, and $16.1 billion of debt.
How big is Centene?
It serves about 25.9 million members at risk, including 12.1 million in Medicaid and 3.5 million in the Marketplace.